 CAMBRIDGE, Mass., June 17, 2021 PRNewswire -- Synlogic, Inc. Nasdaq: SYBX, a clinical stage company bringing the transformative potential of synthetic biology to medicine, announced today that it has entered into a research collaboration agreement with Roche for the discovery of a novel Synthetic BioticTM medicine for the treatment of inflammatory bowel disease IBD. 